5 Mayıs 2023 |
|
|
| 08.50-09.00 |
Introduction |
|
Hakan Yaralı |
|
|
| |
|
| 09.00-09.30 |
Key-note Lecture-1 |
|
Chair: Hakan Yaralı |
|
|
|
|
|
Cappadocia |
|
Victor Gomel |
|
|
| |
|
| 09.30-10.00 |
Key-note Lecture-2 |
|
Chair: Semra Kahraman |
|
|
|
|
|
AI in the IVF Lab: A SWOT analysis |
|
Nikica Zaninovic |
| |
|
| 10.00-10.30 |
Kahve Arası |
|
|
| |
|
| 10.30-12.30 |
Session-1 |
|
Chairs: Robert Fischer, Mehtap Polat |
|
|
|
|
|
POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART |
|
|
| |
|
| 10.30-11.00 |
The WHY, the WHAT, and the HOW |
|
Carlo Alviggi |
| 11.00-11.30 |
The ART calculator: a validated tool to predict reproductive success in ART |
|
Sandro Esteves |
|
|
| 11.30-12.00 |
Management strategies in POSEIDON groups 1 and 2 patients |
|
Peter Humaidan |
|
|
| 12.00-12.30 |
Management strategies in POSEIDON groups 3 and 4 patients |
|
Robert Fischer |
|
|
| |
|
| 12.30-14.00 |
Öğle Arası |
|
|
| |
|
| 14.00-14.30 |
Key-note Lecture-3 |
|
Chair: Bülent Urman |
|
|
|
|
|
Present and future in gametes and embryo manipulation and selection |
|
Laura Rienzi |
|
|
| |
|
| 14.30-16.00 |
Session-2 |
|
Chair: Gürkan Uncu, Cem Atabekoğlu |
|
|
|
|
|
Add-ons in IVF |
|
|
| |
|
| 14.30-15.00 |
Androgen pre-treatment |
|
Panagiotis Drakopoulos |
| 15.00-15.30 |
Endometrial scratching |
|
Ben Mol |
| 15.30-16.00 |
Sperm DNA fragmentation |
|
Sandro Esteves |
| |
|
| 16.00-16.30 |
Kahve Arası |
| |
|
| 16.30-18.00 |
Session-3 |
|
Chair: Başak Balaban, İrem Yaralı Özbek |
|
|
|
|
|
How steady is your IVF program really? |
|
|
| |
|
| 16.30-17.00 |
A safe and effective lab: Design vs. functionality |
|
Ronny Janssens |
| 17.00-17.30 |
How steady is embryo culture in your lab really? |
|
Sharon Mortimer |
| 17.30-18.00 |
How clinical decisions may impact key performance indicators (KPIs) in the IVF laboratory? |
|
David Mortimer |
|
|
| |
|
6 Mayıs 2023 |
|
|
| 09.00-09.30 |
Key-note Lecture-4 |
|
Chair: Lale Karakoç Sökmensüer |
|
|
|
|
|
AI in ART |
|
Laura Rienzi |
|
|
| |
|
|
|
| 09.30-10.30 |
Panel-1 |
|
Chair: Hakan Yaralı |
|
|
| |
|
| |
Time to personalize luteal phase support- Fresh and FET Cycles |
|
|
|
|
| |
Peter Humaidan |
|
Shahar Kol |
|
|
| |
Raoul Orvieto |
|
Panagiotis Drakopoulos |
|
|
| |
|
| 10.30-11.00 |
Kahve Arası |
| |
|
| 11.00-12.30 |
Session-4 |
|
|
|
Chair: Ahmet Zeki Işık, Göğşen Önalan |
|
|
|
|
|
Emerging Methods for Embryo Selection |
|
|
| |
|
| 11.00-11.30 |
Use of PGT-A in ART: Benefit or costly add-on? |
|
Alberto Vaiarelli |
| 11.30-12.00 |
niPGT-A, Should We Adopt or Neglect? |
|
Raoul Orvieto |
| 12.00-12.30 |
Non-invasive AI based decision tools |
|
Nikica Zaninovic |
| |
|
| 12.30-14.00 |
Öğle Arası |
| |
|
| 14.00-14.30 |
Key-note lecture-5 |
|
|
|
Chair: Barış Ata |
|
|
|
|
| |
The search for the best protocol to prepare endometrium for FET cycles continues… |
|
Peter Humaidan |
| |
|
| 14.30-16.00 |
Session-5 |
|
|
|
Chair: Cem Demirel, Robert Najdecki |
|
|
|
|
|
Ovarian Stimulation |
|
|
| |
|
| 14.30-15.00 |
Mild/moderate versus full ovarian stimulation |
|
Carlo Alviggi |
| 15.00-15.30 |
Dual Stimulation-Where do we stand? |
|
Alberto Vaiarelli |
| 15.30-16.00 |
Is the long antagonist protocol safe, steady and unfailing? |
|
Vaggelis Papanikolaou |
| |
|
| 16.00-16.30 |
Kahve Arası |
| |
|
| 16.30-18.00 |
Session-6 |
|
|
|
Chair: Gürkan Bozdağ, Ercan Baştu |
|
|
|
|
|
Controversies and challenges in daily IVF practice |
|
|
| |
|
| 16.30-17.00 |
Dysmorphic uterus, is it a real infertility problem? Is the solution surgical? |
|
Ben Mol |
| 17.00-17.30 |
Advances in Clinical and Laboratory Techniques for Obstructive and Non-Obstructive Azoospermia |
|
Sandro Esteves |
| 17.30-18.00 |
Low grade blastocysts result in healthy live births and should not be discarded! |
|
Ben Mol |
| |
|
7 Mayıs 2023 |
|
|
| 08.30-09.00 |
Akılcı İlaç Sunumu |
|
Sezcan Mümüşoğlu |
|
|
|
|
| 09.00-09.30 |
Key-note Lecture-6 |
|
Chair: Mustafa Bahçeci |
|
|
|
|
|
ART success in the current era |
|
Sesh Sunkara |
|
|
| |
|
|
|
| 09.30-10.00 |
Key-note Lecture-7 |
|
Chair: Sezcan Mümüşoğlu, Berfu Demir |
|
|
|
|
|
Individualized ovarian stimulation: how can segmentation improve outcomes? |
|
Thomas M. D’Hooghe |
|
|
| |
|
|
|
| 10.00-10.30 |
Kahve Arası |
| |
|
| 10.30-12.00 |
Session-7 |
|
Chair: Necati Fındıklı, Kübra Boynukalın |
|
|
| |
|
| |
Safety and Quality in ART |
|
|
|
|
| 10.30-11.00 |
Is the "well-run lab" enough? Risk and safety management in ART |
|
Ronny Janssens |
|
|
| 11.00-11.30 |
SOARing quality management in ART |
|
David Mortimer |
| 11.30-12.00 |
“Building an Effective Team” |
|
Sharon Mortimer |
|
|
| |
|
| 12.00-12.10 |
Closing |
|
|
|
Hakan Yaralı |
